At the Intelligent Health UK 2023 summit, the world’s largest community in emerging technology and AI in medicine, met in London this May.

In his keynote speech ‘ When personalised care meets technology’ , Prof. Richard Simcock - Chief Medical Officer at Macmillan Cancer Support and one of UK’s leading breast oncologists - championed the use of PROMs and My Clinical Outcomes (MCO) in cancer care.

He also shared his ideas on how PROMs and AI can be combined to achieve great benefits in one of the current biggest challenges in healthcare: saving clinical time.

During his speech, centred around the importance of not loosing sight of compassionate and patient-centred care, despite the welcome technology innovation, he highlights the benefits of using MCO in his clinics and how he thinks PROMs should be ‘operationalised in the flow of care'.

Prof. Simcock shared the benefits of using MCO with his patients:

• MCO allows patients to regularly report on their quality of life so that ‘ we can triage problems efficiently in a good quality conversation (with patients)’, and ‘it makes clinic efficient’ .

• MCO also allows ‘at scale, and quickly, to see what are the problems for the community of patients that I treat’ and to implement improvement initiatives.

Commenting on the opportunity to combine AI and PROMs, Prof. Richard Simcock said:

‘If we could use this (PROMs) to identify patients who don’t need to be seen, (..) take AI to identify patients with low levels of reported outcomes, combining them with bio-chemical haematological data and triage them into remote, telephone or even AI-led clinics (..) it would be possible to save (..) clinical time. ‘

Prof. Richard Simcock, Chief Medical Officer at Macmillan Cancer Support.

To hear about the use of MCO in Prof. Richard Simcock’s keynote speech, begin watching the video from 9:48minutes.

More News